Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.

HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge residual infected cells in individuals on ART are urgently needed. Here, we demonstrate that CD4+ T cell-associated HIV-1 RNA is often highly en...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Louise E Hogan, Joshua Vasquez, Kristen S Hobbs, Emily Hanhauser, Brandon Aguilar-Rodriguez, Rajaa Hussien, Cassandra Thanh, Erica A Gibson, Alexander B Carvidi, Louis C B Smith, Shahzada Khan, Martin Trapecar, Shomyseh Sanjabi, Ma Somsouk, Cheryl A Stoddart, Daniel R Kuritzkes, Steven G Deeks, Timothy J Henrich
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2018
Materias:
Acceso en línea:https://doaj.org/article/5f48aaf0ac6f4de885d57506c67f973f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5f48aaf0ac6f4de885d57506c67f973f
record_format dspace
spelling oai:doaj.org-article:5f48aaf0ac6f4de885d57506c67f973f2021-12-02T19:59:40ZIncreased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.1553-73661553-737410.1371/journal.ppat.1006856https://doaj.org/article/5f48aaf0ac6f4de885d57506c67f973f2018-02-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.1006856https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge residual infected cells in individuals on ART are urgently needed. Here, we demonstrate that CD4+ T cell-associated HIV-1 RNA is often highly enriched in cells expressing CD30, and that cells expressing this marker considerably contribute to the total pool of transcriptionally active CD4+ lymphocytes in individuals on suppressive ART. Using in situ RNA hybridization studies, we show co-localization of CD30 with HIV-1 transcriptional activity in gut-associated lymphoid tissues. We also demonstrate that ex vivo treatment with brentuximab vedotin, an antibody-drug conjugate (ADC) that targets CD30, significantly reduces the total amount of HIV-1 DNA in peripheral blood mononuclear cells obtained from infected, ART-suppressed individuals. Finally, we observed that an HIV-1-infected individual, who received repeated brentuximab vedotin infusions for lymphoma, had no detectable virus in peripheral blood mononuclear cells. Overall, CD30 may be a marker of residual, transcriptionally active HIV-1 infected cells in the setting of suppressive ART. Given that CD30 is only expressed on a small number of total mononuclear cells, it is a potential therapeutic target of persistent HIV-1 infection.Louise E HoganJoshua VasquezKristen S HobbsEmily HanhauserBrandon Aguilar-RodriguezRajaa HussienCassandra ThanhErica A GibsonAlexander B CarvidiLouis C B SmithShahzada KhanMartin TrapecarShomyseh SanjabiMa SomsoukCheryl A StoddartDaniel R KuritzkesSteven G DeeksTimothy J HenrichPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 14, Iss 2, p e1006856 (2018)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Louise E Hogan
Joshua Vasquez
Kristen S Hobbs
Emily Hanhauser
Brandon Aguilar-Rodriguez
Rajaa Hussien
Cassandra Thanh
Erica A Gibson
Alexander B Carvidi
Louis C B Smith
Shahzada Khan
Martin Trapecar
Shomyseh Sanjabi
Ma Somsouk
Cheryl A Stoddart
Daniel R Kuritzkes
Steven G Deeks
Timothy J Henrich
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
description HIV-1-infected cells persist indefinitely despite the use of combination antiretroviral therapy (ART), and novel therapeutic strategies to target and purge residual infected cells in individuals on ART are urgently needed. Here, we demonstrate that CD4+ T cell-associated HIV-1 RNA is often highly enriched in cells expressing CD30, and that cells expressing this marker considerably contribute to the total pool of transcriptionally active CD4+ lymphocytes in individuals on suppressive ART. Using in situ RNA hybridization studies, we show co-localization of CD30 with HIV-1 transcriptional activity in gut-associated lymphoid tissues. We also demonstrate that ex vivo treatment with brentuximab vedotin, an antibody-drug conjugate (ADC) that targets CD30, significantly reduces the total amount of HIV-1 DNA in peripheral blood mononuclear cells obtained from infected, ART-suppressed individuals. Finally, we observed that an HIV-1-infected individual, who received repeated brentuximab vedotin infusions for lymphoma, had no detectable virus in peripheral blood mononuclear cells. Overall, CD30 may be a marker of residual, transcriptionally active HIV-1 infected cells in the setting of suppressive ART. Given that CD30 is only expressed on a small number of total mononuclear cells, it is a potential therapeutic target of persistent HIV-1 infection.
format article
author Louise E Hogan
Joshua Vasquez
Kristen S Hobbs
Emily Hanhauser
Brandon Aguilar-Rodriguez
Rajaa Hussien
Cassandra Thanh
Erica A Gibson
Alexander B Carvidi
Louis C B Smith
Shahzada Khan
Martin Trapecar
Shomyseh Sanjabi
Ma Somsouk
Cheryl A Stoddart
Daniel R Kuritzkes
Steven G Deeks
Timothy J Henrich
author_facet Louise E Hogan
Joshua Vasquez
Kristen S Hobbs
Emily Hanhauser
Brandon Aguilar-Rodriguez
Rajaa Hussien
Cassandra Thanh
Erica A Gibson
Alexander B Carvidi
Louis C B Smith
Shahzada Khan
Martin Trapecar
Shomyseh Sanjabi
Ma Somsouk
Cheryl A Stoddart
Daniel R Kuritzkes
Steven G Deeks
Timothy J Henrich
author_sort Louise E Hogan
title Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
title_short Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
title_full Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
title_fullStr Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
title_full_unstemmed Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
title_sort increased hiv-1 transcriptional activity and infectious burden in peripheral blood and gut-associated cd4+ t cells expressing cd30.
publisher Public Library of Science (PLoS)
publishDate 2018
url https://doaj.org/article/5f48aaf0ac6f4de885d57506c67f973f
work_keys_str_mv AT louiseehogan increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT joshuavasquez increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT kristenshobbs increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT emilyhanhauser increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT brandonaguilarrodriguez increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT rajaahussien increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT cassandrathanh increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT ericaagibson increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT alexanderbcarvidi increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT louiscbsmith increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT shahzadakhan increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT martintrapecar increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT shomysehsanjabi increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT masomsouk increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT cherylastoddart increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT danielrkuritzkes increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT stevengdeeks increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
AT timothyjhenrich increasedhiv1transcriptionalactivityandinfectiousburdeninperipheralbloodandgutassociatedcd4tcellsexpressingcd30
_version_ 1718375724215173120